1-11 of 11
signaling lymphocytic activation molecule family
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Ethel Cesarman, MD PhD, Mikhail Roshal, MD PhD, Jonathan Reichel, PhD, Wagner Florian, PhD, Bhavneet Binder, Sakellarios Zairis, Jouliana Sadek, PhD, Joshua Brody, MD, Raul Rabadan, PhD, Sandeep Dave, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 549.
https://doi.org/10.1182/blood-2019-131163
Published: 2019
Journal Articles

Antibody Based Three-Drug Regimens for Multiple Myeloma - a Systematic Review of Phase II and Phase III Clinical Trials

Arafat Ali Farooqui, MD, Humaira Sarfraz, MD, Zunairah Shah, MBBS, Muhammad Saad Farooqi, MD, Maimoona Khan, MBBS, Aqsa Ashraf, MD, Ahmad Anjum, MD, Talha Bin Farooq, MD, Tanveer Shaukat, MD, Ali Younas Khan, MD, Madeeha Shafqat, Muhammad Junaid Tariq, MD, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5546.
https://doi.org/10.1182/blood-2019-121999
Published: 2019
Journal Articles

Efficacy of Elotuzumab Based Combinations in Patients with Multiple Myeloma - a Systematic Review

Arafat Ali Farooqui, MD, Ahmad Anjum, MD, Muhammad Saad Farooqi, MD, Talha Bin Farooq, MD, Tanveer Shaukat, MD, Aqsa Ashraf, MD, Humaira Sarfraz, MD, Zunairah Shah, MBBS, Muhammad Junaid Tariq, MD, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5548.
https://doi.org/10.1182/blood-2019-122395
Published: 2019
Journal Articles

Hypomethylating Agent 5-Azacytidine Sensitizes Peripheral T-Cell Lymphoma to SLAMF7-Targeting Therapeutic Antibody, Elotuzumab

Neetha Parameswaran, PhD, Xiaoxian Zhao, PhD, Juraj Bodo, PhD, Lisa Durkin, Yvonne Parker, Daniel Lindner, MD PhD, Eric D. Hsi, MD, Deepa Jagadeesh, MDMPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 1515.
https://doi.org/10.1182/blood-2019-131800
Published: 2019
Journal Articles

Safety and Efficacy of Elotuzumab with Lenalidomide/Dexamethasone for Multiple Myeloma in a Japanese Subpopulation Analysis of the Phase 3 Eloquent-2 Trial

Kazuteru Ohashi, Kenshi Suzuki, MD PhD, Kazutaka Sunami, MD PhD, Shinsuke Iida, MD PhD, Shinichiro Okamoto, MD PhD, Hiroshi Handa, MD PhD, Kosei Matsue, MD PhD, Masafumi Miyoshi, Eric Bleickardt, MD, Morio Matsumoto, MD, Masafumi Taniwaki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3315.
https://doi.org/10.1182/blood.V128.22.3315.3315
Published: 2016
Journal Articles

Dissecting the Mechanisms of Activity of SLAMF7 and the Targeting Antibody Elotuzumab in Multiple Myeloma

Siobhan Glavey, MD, Michaela Reagan, PhD, Salomon Manier, MD, Michele Moschetta, MD, Yawara Kawano, MDPhD, Antonio Sacco, BS, Aldo M Roccaro, MD PhD, Michael Robbins, BS, Irene M. Ghobrial, MD
Journal: Blood
Blood (2014) 124 (21): 3431.
https://doi.org/10.1182/blood.V124.21.3431.3431
Published: 2014
Journal Articles

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Markus Ertmer, Djordje Atanackovic, Lucia Vankann, Stefan Wilop, MD, Eray Gökkurt, MD, Tim H Brümmendorf, Jens Panse, MD
Journal: Blood
Blood (2012) 120 (21): 4969.
https://doi.org/10.1182/blood.V120.21.4969.4969
Published: 2012
Journal Articles

Hypoxia Influences Gene Expression and Growth Characteristics of HS-5 Stromal Cells and Its Interaction with CLL

Amit K. Mittal, PhD, DVM, MS, Yun Liu, MS, Xiao-Jie Yan, MD PhD, Barbara A. Sherry, PhD, Nicholas Chiorazzi, MD
Journal: Blood
Blood (2012) 120 (21): 3882.
https://doi.org/10.1182/blood.V120.21.3882.3882
Published: 2012
Journal Articles

The Combination of AMD3100 Plus GROβ Rapidly Mobilizes Hematopoietic Stem Cells with Enhanced Homing, Adhesion and Survival Properties

Louis M. Pelus, PhD, Pratibha Singh, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 71.
https://doi.org/10.1182/blood.V112.11.71.71
Published: 2008
Journal Articles

Correction of the Skin Defect in Murine Recessive Dystrophic Epidermolysis Bullosa by Bone Marrow Derived SLAM Family Receptor Enriched Cells.

Jakub Tolar, MD, PhD, Ron T. McElmurry, B.S., Hisham Bazzi, Ph.D., Lily Xia, B.S., Akemi Ishida-Yamamoto, M.D., Angela M. Christiano, M.D., Bruce R. Blazar, M.D.
Journal: Blood
Blood (2007) 110 (11): 435.
https://doi.org/10.1182/blood.V110.11.435.435
Published: 2007
Journal Articles

Differential Expression of SLAM Family Receptor Markers in Normal Human Hematopoietic Stem Cells and Their Malignant Counterpart in MDS and AML.

Ramon V. Tiu, MD, Jennifer J. Powers, Abdo Haddad, MD, Ying Jiang, MD,PhD, Jaroslaw P. Maciejewski, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 1897.
https://doi.org/10.1182/blood.V108.11.1897.1897
Published: 2006